IUPAC-IUB Commission on Biochemical Nomenclature (CBN)
World Wide Web version prepared by G. P. Moss
School of Physical and Chemical Sciences, Queen Mary University of London,
Mile End Road, London, E1 4NS, UK
These recommendations are as close as possible to the printed version [see Biochem. J., 1975, 151, 1-4; Biochemistry, 1975, 14, 2559-2560; Biochim. Biophys. Acta 1975, 404, 152-155; Eur. J. Biochem., 1975, 55, 485-486; J. Biol. Chem., 1975, 250, 3215-3216; Biochemical Nomenclature and Related Documents, 2nd edition, Portland Press, 1992, pages 82-83; copyright IUPAC and IUBMB; reproduced with the permission of IUPAC and IUBMB]. If you need to cite these rules please quote these references as their source. In the web version footnotes have been converted into notes following the paragraph to which they apply.
Any comments should be sent to any member of the Committee
In the last two decades, the structures of many peptide hormones have been elucidated and other peptide hormones have been obtained in pure form. However, there are presently no accepted guidelines for nomenclature in this field. Therefore, the IUPAC-IUB Commission on Biochemical Nomenclature (CBN) appointed a subcommittee consisting of R. A. Acher, R. A. Boissonnas, H. B. F. Dixon, R. Guillemin, P. Karlson (Convenor), H. Rasmussen, J. Rudinger, and N. A. Yudayev to discuss the question of the nomenclature of peptide hormones and to report to CBN. The International Union of Physiological Sciences nominated, as consultants to the subcommittee, A. Brodish, S. M. McCann, and F. Ulrich. The present Recommendations are based on the report of this subcommittee.
1. General Principles
Naturally occurring oligo- and polypeptides are generally referred to by trivial names; their systematic names are so cumbersome that they are of little use. Most of the peptide hormones already have well established trivial names indicating either natural source (e.g. insulin) or physiological action (e.g. relaxin, prolactin). However, some of the trivial names are so long that these hormones are known mainly by abbreviations (e.g. FSH for follicle-stimulating hormone). This is unfortunate, and it was therefore considered advisable to create suitable names for those peptide hormones not already having well established short trivial names. Three principles have been observed:
(a) new names for hormones of the adenohypophysis bear the ending "-tropin";
(b) hypothalamic releasing factors (hormones) bear the ending "-liberin";
(c) hypothalamic release-inhibiting factors (hormones) bear the ending "-statin" (see below).
2. Trivial Names
The trivial names proposed for peptide hormones are given in the "Appendix." Abbreviations of the new names are not proposed, and the use of currently fashionable abbreviations is discouraged.
3. Species Designation
Since peptide hormones show species variation in their amino-acid sequence, their names are essentially "generic names", and are insufficient to specify a single chemical compound. It is therefore recommended that authors add to the name of each hormone the species from which the hormone was isolated, or at least indicate the biological source(s) where appropriate in each paper.
4. Special Groups of Hormones
(a) Hypothalamic Factors (Hormones) - The hypothalamic "releasing factors" or "releasing hormones" have no well established trivial names. It is recommended that the trivial names given in the "Appendix" be used for the releasing factors (hormones). They are based on the ending "-liberin" added to the prefix of the pituitary hormone released by the factor. Thus, "thyroliberin" indicates the hypothalamic peptide stimulating the release (and perhaps also the biosynthesis) of thyrotropin, the corresponding tropic hormone, from the pituitary gland. (Note that the ending "-tropin" is no longer retained in the name; it is implied in the definition of "-liberin".)
The names of those factors inhibiting the release (and perhaps the synthesis) of pituitary hormones are formed in a similar way with the suffix "-statin. "
(b) Pituitary Hormones - Most of the hormones ofthe adenohypophysis have acceptable trivial names ending in -tropin. The committee has created the missing names for follicle-stimulating hormone, "follitropin," and for luteinizing hormone, "lutropin." It is recommended that pituitary hormones discovered in the future also be named with the ending -tropin, This suffix should be restricted to pituitary and similar hormones and should not be used for, e.g. crustacean hormones acting on pigment cells.
Note The committee has re-evaluated the arguments for and against the suffix "-trophin," still used by many anatomists and physiologists. Since the bioassay systems are based mostly on effects other than the trophic one, it was decided to recommend "-tropin" for general usage in biochemistry.
Some placental hormones are physiologically very similar to pituitary hormones. They are named accordingly with the prefix "chorio-", e.g. choriogonadotropin for chorionic gonadotropin.
(c) Invertebrate Peptide Hormones -Though some of the invertebrate peptide hormones have been isolated in pure form and their amino-acid compositions have been determined, the field has not yet developed to a stage where a list of names seems warranted.
It is, however, recommended that the suffixes defined above for hypothalamic and pituitary hormones not be used in a different sense in invertebrates. Thus, a crustacean color change hormone acting on, e.g. erythrophores, should not be named "erythrotropin," a hormone causing release of eggs and/or sperm in sea urchins should not be called "gametoliberin."
Appendix. List of Peptide Hormonesa
|Trivial name||Other names||Current abbreviationb|
|1. Hypothalamic Factors|
|Luliberin||Lutemizing hormone-releasing factor||LH-RF (LRF)|
|Melanostatin||Melanotropin release-inhibiting factor||MIF|
|Prolactostatin||Prolactin release-inhibiting factor||PIF|
growth hormone-releasing factor
|Somatostatin||Somatotropin release-inhibiting factor|
|2. Pituitary and Related Hormones|
(Interstitial cell-stimulating hormone)
|Prolactin||Mammatropic hormone; mammatropin;|
lactotropic hormone; lactotropin
|Urogonadotropink||(Human) Menopausal gonadotropin||HMG|
|Vasopressin||Adiuretin; antidiuretic hormone||VP, ADH|
|3. Other Peptide Hormones|
|Gastrin sulphate||Gastrin II|
|Parathyrinl||Parathyroid hormone; Parathormone|
b Abbreviations, old or new, are not recommended; they are given here for identification purposes only.
c This name indicates a hypothalamic substance releasing gonadotropin. It may also be used for the decapeptide isolated from pig hypothalami and known as luteinizing hormone/follicle-stimulatinghormone releasing factor, abbreviated LH/FSH-RF,b since the peptide induces the release of both lutropin and follitropin in constant proportions and thus carries the activity of both luliberin and folliberin (see also Footnote e).
d The chorionic gonadotropins have in most species (including man) the action of both follitropin and lutropin and are therefore termed "gonadotropins."
e Gonadotropin is to be used for hormones having the activity of both follitropin and lutropin, like the gonadotropins of cold-blooded vertebrates. It may also be used for impure preparations containing lutropin and follitropin.
f In elasmobranch fishes.
g In bony fishes.
h Two peptides have been sequenced and designated a-melanotropin and b-melanotropin.
i In birds and reptiles.
j The name of this hormone is derived from Greek wkntokos (OKYTOKOS = fast birth, prompt delivery), not from the Greek oxns (oxys = acid; fast). The spelling ocytocin should therefore be preferred; moreover, it avoids confusion with oxy, meaning "related to oxygen." However, oxytocin is in wide use, especially in the English language. Therefore, both spellings are listed as optional.
k Most work has been done on the human hormone, known as Human Menopausal Gonadotropin (HMG); it is a pituitary hormone, chemically changed during passage through the kidney. Due to its occurrence in urine, it has been termed "urogonadotropin."
l Parathyrin is a new name suggested here. The synonym Parathormone is a proprietary name.
m The name "somatomedin" was suggested by a group working in the field (Nature 235, 107 (1972)).
n A polypeptide from the thymus. The name proposed was suggested in a letter to Nature (249, 863 (1974)) to avoid confusion with the earlier "thymine" from nucleic acids. "Thymin" should be abandoned.
Return to IUPAC Chemical Nomenclature Homepage